Report overview
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15?30 years.
This report aims to provide a comprehensive presentation of the global market for Ankylosing Spondylitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ankylosing Spondylitis Treatment. This report contains market size and forecasts of Ankylosing Spondylitis Treatment in global, including the following market information:
Global Ankylosing Spondylitis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Ankylosing Spondylitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.
We surveyed the Ankylosing Spondylitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ankylosing Spondylitis Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Ankylosing Spondylitis Treatment Market Segment Percentages, by Type, 2022 (%)
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics
Global Ankylosing Spondylitis Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Ankylosing Spondylitis Treatment Market Segment Percentages, by Application, 2022 (%)
Juveniles
Adults
Global Ankylosing Spondylitis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Ankylosing Spondylitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ankylosing Spondylitis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ankylosing Spondylitis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ankylosing Spondylitis Treatment, market overview.
Chapter 2: Global Ankylosing Spondylitis Treatment market size in revenue.
Chapter 3: Detailed analysis of Ankylosing Spondylitis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ankylosing Spondylitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
